e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Pulmonary fibrosis: mechanisms of disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Luca Tamò (Bern, Switzerland), Luca Tamò, Amiq Gazdhar, Anis Feki, Thomas Geiser
Source:
International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Session:
Pulmonary fibrosis: mechanisms of disease
Session type:
Thematic Poster Session
Number:
944
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luca Tamò (Bern, Switzerland), Luca Tamò, Amiq Gazdhar, Anis Feki, Thomas Geiser. The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung. Eur Respir J 2015; 46: Suppl. 59, 944
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Regulation and role of notch signaling in epithelial progenitor cell differentiation and proliferation in the normal and the fibrotic lung
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway
Source: International Congress 2014 – ILDs 1
Year: 2014
Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012
LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Mesenchymal stem cells and conditioned medium in myofibroblast modulation and collagen production in vascular adventitia and parenchyma of experimental pulmonary fibrosis model
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Identification and characterization of mesenchymal stem cells in the human lung
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Lung-derived mesenchymal stromal cells are tissue specific and display an altered gene expression in BOS patients
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010
LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept